X-ray diffraction, thermogravimetric (TGA), differential scanning calorimetric (DSC), and impedance analysis were used to study the reported high-temperature phase transitions at 107, 149, 230, and 256 °C in crystals of cesium dihydrogen phosphate, CsH2PO4 (CDP). Our results show strong evidence that at all these temperatures, the observed DSC or differential thermal analysis (DTA) endothermic effects appear only as a consequence of a dehydration process starting on the surface of the crystal. Our results thus show that the reported transition at 230 °C is not a polymorphic transition. This means that the monoclinic symmetry, stable at room temperature, with space group P21/m–C2k2, is maintained up to the final decomposition. Moreover, since we have not found any evidence for the existence of a superprotonic high-temperature phase above 230 °C, the high conductivity above 230 °C is thus only a consequence of the dehydration of the crystal surface.
The sequence of previously found phase transitions in
CsHSO4 at around
60, 122, and 141 °C
was carefully examined by using thermo-gravimetric analysis (TGA), mass
spectroscopy (MS), differential thermal analysis, ac calorimetry, impedance
spectroscopy, and x-ray diffraction (XRD). Our results show evidence that at all these
transition temperatures, the dehydration processes take place at or very near
the surface of the crystal. As a consequence, our results support the phase of
CsHSO4 above
141 °C
being not a superprotonic-conducting phase but rather a mixture of
CsHSO4 and
Cs2S2O7 caused
by a partial thermal decomposition that includes the break-up of hydrogen bonds and the formation
of H2O
molecules.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.